EUVIMEDEUVIMED entdecken
Crossref

COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes

Ruth Fair-Mäkelä iD, Pinja Thorén iD, Joni Näsiaho iD, Pia Sundqvist iD, Irina Piiroinen, Laura Kähäri iD, Ilkka Julkunen, Johanna Ivaska iD, Elin Hub, Antal Rot iD, Bishwa Ghimire iD, Jonna Alanko iD und 1 weitere

Science Immunology · 15.08.2025 · 10 (110)

DOI: 10.1126/sciimmunol.adr6787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 15.08.2025. Verfasst von Ruth Fair-Mäkelä und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Lymph Nodes, COVID-19 Vaccines, Stromal Cells, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 92 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymph node (LN) stromal cells are critical regulators of immune reactions, yet their responses to different SARS-CoV-2 vaccines remain unexplored. Here, we immunized mice with clinically approved gene- and protein-based COVID-19 vaccines targeting viral spike (S) protein and analyzed the draining LN stroma using multimodal bioimaging, single-cell transcriptomics, and functional studies. We found that messenger RNA and adenovirus vector vaccines transfected lymphatic endothelial cell and fibroblastic reticular cell subsets in vivo and led to early local S protein production in the draining LN in a vaccine-specific manner. The vaccines induced rapid transcriptomic reprogramming of the LN stromal cells, which functionally altered scavenging and parenchymal transfer of lymph-borne antigens, formation of chemokine gradients, and migration of eosinophils within LNs. Thus, distinct vaccine formulations targeting S protein differentially prime the draining LN stromal cells before the arrival of migratory dendritic cells bearing immunogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymph NodesCOVID-19 VaccinesStromal CellsCOVID-19SARS-CoV-2AnimalsMiceSpike Glycoprotein, CoronavirusMice, Inbred C57BLFemaleDendritic CellsHumansCellular ReprogrammingCell Movement

Substanzen

COVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Institute of Biomedicine, University of Turku, Turku, Finland.
  • InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
  • MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Turku Bioscience, University of Turku, Turku, Finland.
  • Department of Life Technologies, University of Turku, Turku, Finland.
  • Foundation for the Finnish Cancer Institute, Helsinki, Finland.

ORCID-Profile: Ruth Fair-Mäkelä, Pinja Thorén, Joni Näsiaho, Pia Sundqvist, Laura Kähäri, Johanna Ivaska, Antal Rot, Bishwa Ghimire, Jonna Alanko, Marko Salmi

Zitieren

APA

Fair-Mäkelä, R., Thorén, P., Näsiaho, J., Sundqvist, P., Piiroinen, I., Kähäri, L., Julkunen, I., Ivaska, J., Hub, E., Rot, A., Ghimire, B., Alanko, J., & Salmi, M. (2025). COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes. Science Immunology, 10(110). https://doi.org/10.1126/sciimmunol.adr6787

Vancouver

Fair-Mäkelä R, Thorén P, Näsiaho J, Sundqvist P, Piiroinen I, Kähäri L, et al. COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes. Science Immunology. 2025;10(110). doi:10.1126/sciimmunol.adr6787

BibTeX
@article{FairMkel2025,
  author = {Fair-Mäkelä, Ruth and Thorén, Pinja and Näsiaho, Joni and Sundqvist, Pia and Piiroinen, Irina and Kähäri, Laura and Julkunen, Ilkka and Ivaska, Johanna and Hub, Elin and Rot, Antal and Ghimire, Bishwa and Alanko, Jonna and Salmi, Marko},
  title = {COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes},
  journal = {Science Immunology},
  year = {2025},
  volume = {10},
  number = {110},
  doi = {10.1126/sciimmunol.adr6787}
}
Kostenlos starten →